• Profile
Close

Lymphocyte immunotherapy for recurrent miscarriages: Predictors of therapeutic success

American Journal of Reproductive Immunology Feb 26, 2018

Cavalcante MB, et al. - Herein, researchers assessed the predictors of therapeutic success in women with a history of recurrent miscarriages (RMs) having undergone lymphocyte immunotherapy (LIT). The factors that were associated with LIT failure included age, the number of previous miscarriages, and the association between autoantibodies and thrombophilia. In cases of secondary RM, it was noted that a higher number of previous miscarriages led to better LIT outcomes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay